Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 29, 2026
Why Is AXIS Capital Holdings (AXS) Stock Down -8.92% Today?

Why Is AXIS Capital Holdings (AXS) Stock Down -8.92% Today?

Key Takeaways

  • AXIS Capital Holdings shares plummeted 8.92% to $108.63 in early trading on Wednesday, erasing a significant portion of recent gains following a disappointing second-quarter earnings report.
  • The primary catalyst was a substantial earnings miss: the company reported adjusted EPS of $2.84, falling roughly 12–14% short of the consensus analyst estimate of approximately $3.25.
  • Underwriting deterioration added pressure: the combined ratio climbed to 93.1%, well above the 88.9% recorded a year ago and meaningfully worse than the ~89.7% analysts had projected.
  • Catastrophe losses weighed on results: $80 million in pre-tax catastrophe and weather-related losses — including $49 million from natural catastrophes and $31 million tied to the Middle East conflict — added 5.3 percentage points to the combined ratio.
  • The stock had been trading near 52-week highs heading into the report, making it especially vulnerable to a sell-off when results fell short of elevated expectations.
  • Traders are now focused on the earnings conference call scheduled for today for any forward-looking commentary on pricing trends, exposure management, and the catastrophe loss outlook for the second half of 2026.

Opening Summary

AXS — AXIS Capital Holdings Limited, the Bermuda-based global specialty insurer and reinsurer — saw its shares plunge 8.92% to $108.63 during Wednesday's trading session, down sharply from Tuesday's close of $119.27. The sell-off came in direct response to the company's second-quarter 2026 earnings report, released after the closing bell on July 28, which revealed a significant earnings-per-share miss alongside deteriorating underwriting metrics. While the initial after-hours reaction was relatively contained at roughly -0.65%, the full trading session brought a far more decisive repricing as investors and analysts fully digested the scope of the shortfall.

Earnings Miss Fuels the Sell-Off

AXIS Capital reported adjusted operating earnings of $2.84 per diluted share for the second quarter, a figure that fell sharply below Wall Street's consensus estimate, which ranged from $3.23 to $3.30 depending on the source. The roughly 12–14% shortfall marked one of the company's more notable earnings misses in recent quarters. While total revenue of approximately $1.75 billion came in roughly in line with or slightly above some estimates, it was the bottom-line disappointment that dominated the market's attention.

Net income available to common shareholders came in at $251 million, or $3.38 per diluted share, representing a 16% increase year over year. However, the operating results — which strip out one-time items and are the metric most closely watched by analysts — told a different story entirely. The gap between reported operating EPS and consensus expectations was large enough to rattle a stock that had rallied strongly into the print.

Deteriorating Underwriting Performance

Beyond the headline earnings number, investors zeroed in on the company's combined ratio — a critical measure of underwriting profitability — which came in at 93.1% for the quarter. That represented a 4.2-percentage-point deterioration from the 88.9% posted in the same period a year ago and was notably worse than the approximately 89.7% analysts had modeled. The insurance segment posted a combined ratio of 90.0%, while the reinsurance segment was weighed down further at 94.5%.

A major contributor to the elevated combined ratio was $80 million in pre-tax catastrophe and weather-related losses. Of that total, $49 million stemmed from natural catastrophe events and $31 million was attributed to the ongoing Middle East conflict. Overall underwriting income fell 24% year over year to $143 million, underscoring the headwinds AXIS Capital faced during the quarter.

Vulnerability at Elevated Levels

The severity of Wednesday's drop was amplified by the stock's positioning heading into earnings. AXS shares had risen approximately 7.7% over the prior month and were trading near their 52-week high of $119.99, leaving little room for error. The stock had also gained roughly 22% over the trailing three months and more than 26% over the past year, reflecting strong momentum and elevated investor expectations. When results fell short across multiple dimensions — EPS, combined ratio, and underwriting income — the air came out quickly.

Volume on Tuesday's earnings-day session reached 908,412 shares, well above the 10-day average of roughly 641,000, suggesting active repositioning. Wednesday's trading is on pace to see even heavier volume as institutional and retail participants alike reassess positions.

Market Context and Trading Activity

The sell-off in AXS stood in contrast to broader strength in the property and casualty insurance sector. Several peers, including ACGL (Arch Capital Group) and HIG (The Hartford), were trading at or near 52-week highs on the same day, suggesting that AXIS Capital's problems were company-specific rather than indicative of sector-wide distress. The divergence highlights how severely the market is punishing individual earnings shortfalls, even for companies operating within otherwise healthy industry conditions.

From a technical standpoint, the drop pushed AXS decisively below its 50-day simple moving average of approximately $105.53 — a level that had provided support in recent months. The stock's beta of 0.49 means it typically exhibits lower volatility than the broader market, making Wednesday's nearly 9% intraday swing particularly unusual and notable.

What Comes Next for AXS

The immediate focus now shifts to the company's earnings conference call, scheduled for July 29, where management — led by President and CEO Vince Tizzio — is expected to provide additional context on the quarter and, critically, forward-looking commentary on pricing conditions, exposure management, and the catastrophe loss environment for the second half of 2026. With no formal guidance provided in the earnings press release, the call represents the primary opportunity for the company to reset expectations.

Analyst sentiment had already been tilting cautious in the lead-up to the report: 10 of the last 11 EPS revisions were negative, and Bank of America had previously lowered its price target to $106 in April with a "neutral" rating. That said, the broader analyst consensus entering the print was a "Moderate Buy" with an average price target of roughly $124.45. Whether analysts maintain, trim, or cut their ratings and targets in the wake of this miss will be a key variable for the stock's near-term trajectory. Key risks include the ongoing Atlantic hurricane season, geopolitical tensions affecting insured assets, and the company's strategic pivot away from casualty reinsurance lines — a move that dampens premium growth in the near term but is aimed at improving long-term portfolio quality.

Trending AI Robots

For investors seeking to navigate volatile market conditions with data-driven precision, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to identify opportunities across thousands of tickers. Tickeron hosts hundreds of AI trading bots, each employing distinct strategies, timeframes, and performance metrics — but only those demonstrating the strongest real-time performance under current market conditions are featured in this dynamic, curated section. Whether you are trading insurance stocks like AXS or scanning for momentum across other sectors, exploring the Trending AI Robots can help you discover data-driven approaches tailored to today's market environment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AXS

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


AXS's RSI Oscillator is sitting in oversold zone for 2 days

It is expected that a price bounce should occur soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AXS advanced for three days, in of 342 cases, the price rose further within the following month. The odds of a continued upward trend are .

AXS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 257 cases where AXS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXS as a result. In of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for AXS turned negative on July 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 59 similar instances when the indicator turned negative. In of the 59 cases the stock turned lower in the days that followed. This puts the odds of success at .

AXS moved below its 50-day moving average on August 04, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AXS crossed bearishly below the 50-day moving average on August 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 23 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 55, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.226) is normal, around the industry mean (2.520). P/E Ratio (7.123) is within average values for comparable stocks, (16.959). Dividend Yield (0.018) settles around the average of (0.023) among similar stocks. P/S Ratio (1.112) is also within normal values, averaging (2.555).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AXS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Industry description

Specialty insurance typically caters to niche-markets, and covers items that are special or unique and/or items that are not typically covered under other insurance policies. Restoration or purchase of a one-of-a-kind collector’s item, high-value home, recreational vehicles, sailboat or even jet skis, horses and farms, all-terrain vehicle, funerals, museums and fine art collections are some examples– one or more of which are covered by a specialty insurance provider. In some cases, a specialty insurance could also complement someone’s existing auto, home and umbrella policies. Markel Corp, for Fidelity National Financial, Inc., Assurant, Inc. and Athene Holding Ltd. are examples of specialty insurance providers.

Market Cap

The average market capitalization across the Specialty Insurance Industry is 4.48B. The market cap for tickers in the group ranges from 518.61K to 13.13B. FNF holds the highest valuation in this group at 13.13B. The lowest valued company is PMIR at 518.61K.

High and low price notable news

The average weekly price growth across all stocks in the Specialty Insurance Industry was -3%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 0%. ESNT experienced the highest price growth at 6%, while OSG experienced the biggest fall at -17%.

Volume

The average weekly volume growth across all stocks in the Specialty Insurance Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was 15% and the average quarterly volume growth was -53%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 48
Price Growth Rating: 56
SMR Rating: 76
Profit Risk Rating: 54
Seasonality Score: -29 (-100 ... +100)
View a ticker or compare two or three
AXS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of insurance and reinsurance services

Industry SpecialtyInsurance

Profile
Details
Industry
Property Or Casualty Insurance
Address
92 Pitts Bay Road
Phone
+1 441 496-2600
Employees
2048
Web
https://www.axiscapital.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.